Dividend Assets Capital, LLC Amgen Inc Transaction History

Dividend Assets Capital, LLC

$519 Million
Q3 2024

A detailed history of Dividend Assets Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Dividend Assets Capital, LLC holds 30,645 shares of AMGN stock, worth $9.03 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares

30,645

Previous 29,968 2.26%

Holding current value

$9.03 Million

Previous $9.36 Million 5.46%

% of portfolio

1.9%

Previous 1.92%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $209,450 - $228,406	677 Added 2.26%	30,645 $9.87 Million
Q2 2024 Aug 02, 2024	BUY	$262.75 - $319.31 $698,652 - $849,045	2,659 Added 9.74%	29,968 $9.36 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $12,368 - $14,929	-46 Reduced 0.17%	27,309 $7.76 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $497,847 - $561,631	1,947 Added 7.66%	27,355 $7.88 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $594,290 - $737,828	2,718 Added 11.98%	25,408 $6.83 Million
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $4.84 Million - $5.73 Million	22,597 Added 24297.85%	22,690 $5.04 Million
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $7,613 - $8,472	33 Added 55.0%	93 $23,000
Q1 2022 Apr 12, 2022	SELL	$219.27 - $242.57 $99,987 - $110,611	-456 Reduced 88.37%	60 $15,000
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $42,454 - $49,740	-200 Reduced 27.93%	516 $110,000
Q2 2021 Jul 23, 2021	SELL	$233.58 - $259.14 $59,562 - $66,080	-255 Reduced 26.26%	716 $175,000
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $192,073 - $235,700	971 New	971 $229,000
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $185,884 - $246,534	-1,020 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $192,994 - $248,064	1,020 New	1,020 $246,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dividend Assets Capital, LLC with notifications on news.

Account

Dividend Assets Capital, LLC Amgen Inc Transaction History